StreetInsider.com
DarioHealth (DRIO) Reports Q1 Revenue of $8.06M, Net Loss of $9.9M
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today reported financial results for the first quarter 2022 and provided a corporate and commercial...